Public tenders in Germany

7,249 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brimonidine (excluding DaFo single doses), ATC S01EA05 for the period 01.10.26 - 30.09.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 569456-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Baclofen (excluding oral Dafo.), ATC M03BX01 for the period 01.10.26 - 30.09.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 569918-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Formoterol (excluding IHP at strength 6 µg), ATC R03AC13, for the period 1.10.26–30.9.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 571635-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Fampridin (excluding 14 pieces + 112 pieces), ATC N07XX07 for the period from 01.11.26 to 31.10.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 644787-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active ingredient Nadroparin, ATC B01AB06, valid from 01.11.26 to 31.10.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 640827-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Sulfasalazine (excluding FMR, N2), ATC M01CX02 for the period from 01.11.26 to 31.10.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 645197-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active ingredient Cinacalcet (excluding the standard size N3), ATC H05BX01, valid from 01.11.26 to 31.10.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 640982-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active ingredient Thalidomid, ATC L04AX02, valid from 01.11.26 to 31.10.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 642751-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Interferon beta-1a (exclusively for subcutaneous use), ATC L03AB07 for the period from 01.11.26 to 31.10.28

DAK-Gesundheit, HamburgTED 644964-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient dihydrocodeine, ATC R05DA14 for the period 01.12.2026 - 30.11.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 712475-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Latanoprost (exclusively EDO 30x0,3 ml and 90x0,3ml), ATC S01EE01 for the period 01.12.2026 - 30.11.2028

DAK-Gesundheit, HamburgTED 714510-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient clomipramine, ATC N06AA04 for the period 01.12.2026 - 30.11.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 712872-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient risedronic acid (excl. FTA 5mg and 75mg), ATC M05BA07 for the period 01.12.26-30.11.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 712081-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Apixaban, ATC B01AF02 for the period 01.12.2026 - 30.11.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 711444-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient ezetimibe + atorvastatin (excl. pack size 88 units), ATC C10BA05 for the period 01.12.2026 - 30.11.2028

DAK-Gesundheit, HamburgTED 712959-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Distribution partnership for AI products

Dataport AöR, AltenholzTED 701477-2026

value not stated1 lot

Mon 8 Oct23:59 in Berlin

1075days

Coaching and process support (open house).

Deutsches Zentrum für Luft- und Raumfahrt e.V. (DLR), KölnTED 729521-2026

€3,150,0001 lot

Wed 31 Oct

1098days

Contract for Special Care under § 140a SGB V for the Treatment of Patients via Intravitreal Medication Administration of VEGF Inhibitors (IVI) in Schleswig-Holstein and Hamburg

AOK NordWest, HagenTED 780553-2025

value not stated1 lot, 4 years

Wed 31 Oct12:00 in Berlin

1098days

Open-House-Discount Contracts 2026-16 (aut idem)

Techniker Krankenkasse, HamburgTED 657556-2026

value not stated10 lots

Wed 31 Oct23:58 in Berlin

1098days

Conclusion of a non-exclusive discount agreement pursuant to § 130a paragraph 8 of the German Social Security Code (SGB V) in conjunction with § 31 paragraph 1 of the German Social Security Code (SGB V) for blood glucose test strips, for the period 01.01.26 - 31.12.27 (including V.-option 1 x 24 months)

DAK-Gesundheit, HamburgTED 730043-2025

€11 lot, 2 years

Sat 3 Nov12:00 in Berlin

1101days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.